Serum CrossLaps® (CTX-I) ELISA
Basic Information
- Primary DI
- 05060169690134
- Basic UDI-DI Code
- 5060169690134WH
- Reference
- AC-02F1
- Device Types
- None provided
- Regulation
- Eu Ivdr
- Classification
- Eu Ivd Class B
- Status
- On The Market
- Manufacturer
- Immunodiagnostic Systems Limited
Additional Description
The Serum CrossLaps® (CTX-I) ELISA is an enzyme immunological test for the quantification of degradation products of C-terminal telopeptides of Type I collagen in human serum and plasma. The Serum CrossLaps® (CTX-I) ELISA assay is intended for in vitro diagnostic use as an indication of human bone resorption and may be used as an aid in: - Monitoring bone resorption changes of anti-resorptive therapies (such as hormone replacement therapies (HRT) with hormones or hormone like drugs and bisphosphonate therapies) in postmenopausal women and individuals diagnosed with osteopenia - Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing anti resorptive therapies, such as HRT with hormones or hormone like drugs and bisphosphonate therapies
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0102060304 | CROSS-LINKED C-TELOPEPTIDES |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd Class B) and regulation (EU IVDR).